Status:
COMPLETED
Transcutaneous Electrical Nerve Inhibition Using Medium-frequency Alternating Current
Lead Sponsor:
Jessa Hospital
Conditions:
Anesthesia, Local
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients suffering from neurological disorders often exhibit unwanted sensorimotor activities e.g. spasticity, hypersensitisation, hyper- and dystonia and motor disabilities. Currently, several therap...
Detailed Description
1\. INTRODUCTION AND RATIONALE Patients suffering from neurological disorders often experience undesired sensorimotor activities e.g. hypersensitisation, spasticity and hyper- and dystonia. To overco...
Eligibility Criteria
Inclusion
- Healthy volunteers \> 18 years old
Exclusion
- Musculoskeletal pain
- Neurologic disorder
- Diabetes mellitus
- Hypertension
- Autoimmune disease
- Any type of surgical history
- Allergy for the electrode patches
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04827173
Start Date
April 9 2021
End Date
April 30 2021
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesiology
Hasselt, Belgium, 3500